NewAmsterdam Pharma Company
NAMS
#4233
Rank
NZ$3.52 B
Marketcap
$38.12
Share price
0.75%
Change (1 day)
121.83%
Change (1 year)

NewAmsterdam Pharma Company (NAMS) Fails to deliver data

Key failure to deliver metrics for NewAmsterdam Pharma Company:

A Failure to deliver also known as fails-to-deliver or FTD occurs when a buyer or seller is unable to meet his trading obligations. FTDs for US listed companies are reported to the SEC and published twice a month. Therefore there is a certain delay between the reporting and the publishing of the data.

Failures to deliver for NewAmsterdam Pharma Company (NAMS) - 3 months history

Number of shares, 3 months chart

Biweekly Failures to deliver volume for NewAmsterdam Pharma Company (NAMS) - since 2022

Volume in USD (price x number of shares), data since 2022

NewAmsterdam Pharma Company (NAMS) Failure to deliver volume, Year over Year

Year Volume (Price x Shares) Change
2024NZ$8.1 M-70.1%
2023NZ$27.11 M7084.41%
2022NZ$0.37 M